BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 27875627)

  • 1. Immunotherapy approaches in the treatment of malignant brain tumors.
    Dunn-Pirio AM; Vlahovic G
    Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell immunotherapy for malignant gliomas.
    Luptrawan A; Liu G; Yu JS
    Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine therapies in malignant glioma.
    Oh T; Sayegh ET; Fakurnejad S; Oyon D; Lamano JB; DiDomenico JD; Bloch O; Parsa AT
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):508. PubMed ID: 25431096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
    Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB
    Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
    Akasaki Y; Black KL; Yu JS
    Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in Gliomas.
    Weant MP; Jesús CM; Yerram P
    Semin Oncol Nurs; 2018 Dec; 34(5):501-512. PubMed ID: 30396808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in immunotherapeutic research for glioma therapy.
    Miyauchi JT; Tsirka SE
    J Neurol; 2018 Apr; 265(4):741-756. PubMed ID: 29209782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging immunotherapies for glioblastoma.
    Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic-cell- and peptide-based vaccination strategies for glioma.
    Yamanaka R
    Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of immunotherapy.
    Liebelt BD; Finocchiaro G; Heimberger AB
    Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell based vaccination strategy: an evolving paradigm.
    Filley AC; Dey M
    J Neurooncol; 2017 Jun; 133(2):223-235. PubMed ID: 28434112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Immunotherapies for Glioblastoma Multiforme.
    Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
    Front Immunol; 2020; 11():603911. PubMed ID: 33767690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell vaccines and immunity in glioma patients.
    Wheeler CJ; Black KL
    Front Biosci; 2005 Sep; 10():2861-81. PubMed ID: 15970541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas.
    Leplina OY; Stupak VV; Kozlov YP; Pendyurin IV; Nikonov SD; Tikhonova MA; Sycheva NV; Ostanin AA; Chernykh ER
    Bull Exp Biol Med; 2007 Apr; 143(4):528-34. PubMed ID: 18214316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy in brain tumors].
    De Carli E; Delion M; Rousseau A
    Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dendritic cell therapy for malignant glioma].
    Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
    No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune and viral therapies for malignant primary brain tumors.
    Gardeck AM; Sheehan J; Low WC
    Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.